What can lead to late diagnosis of HIV in an illegal gold mining environment? A qualitative study at the French Guiana's border with Brazil.
Epidemiology
HIV & AIDS
Public health
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
05 09 2022
05 09 2022
Historique:
entrez:
23
1
2023
pubmed:
24
1
2023
medline:
26
1
2023
Statut:
epublish
Résumé
The present study aimed to understand what factors can lead to late HIV diagnosis of illegal gold miners at French Guiana's border with Brazil. An exploratory qualitative study with in-depth interviews and observations was conducted between November 2019 and February 2020. The study was conducted in the main medical healthcare service and two non-governmental organisation premises in the Oyapock border region, which is a supply area for illegal gold mining sites. Fifteen people living with HIV diagnosed with CD4 count <350 cells 10 Three key themes for late HIV diagnosis emerged: (1) the presence of economic and political structural factors which constitute risks for this illegal activity, specifically the repression of gold mining sites by French Armed Forces and the distance from healthcare facilities; (2) representations of the body and health, related to the living conditions of this population; prioritisation of health emergencies and long-term self-medication; and (3) gender roles shaping masculinity and heterosexuality contributing to a perception of not being at risk of HIV and delaying testing. This study highlights structural, group-based and individual factors that reduce access to HIV testing and healthcare in general for a population of migrant workers in an illegal gold mining area. Faced with harsh living conditions and state repression, these workers develop a vision of health which prioritises the functionality of the body. Associated with gender roles which are partly shaped both by the mining activity and its geographical location, this vision can lead to late HIV diagnosis.
Identifiants
pubmed: 36691149
pii: bmjopen-2022-061237
doi: 10.1136/bmjopen-2022-061237
pmc: PMC9445782
doi:
Substances chimiques
Gold
7440-57-5
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e061237Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
AIDS Care. 2017 Jun;29(6):689-695
pubmed: 27690562
BMC Public Health. 2012 Jan 19;12:53
pubmed: 22260085
BMC Public Health. 2019 Dec 4;19(1):1633
pubmed: 31801512
PLoS One. 2018 Jun 22;13(6):e0199267
pubmed: 29933374
PLoS One. 2016 Sep 07;11(9):e0162112
pubmed: 27603317
PLoS One. 2018 May 24;13(5):e0197990
pubmed: 29795698
Cad Saude Publica. 2015 Aug;31(8):1615-22
pubmed: 26375641
PLoS One. 2018 Feb 8;13(2):e0192564
pubmed: 29420591
AIDS. 2018 Mar 13;32(5):539-542
pubmed: 29239892
BMJ Open. 2017 Aug 03;7(8):e016558
pubmed: 28775190
Cad Saude Publica. 2020 Jun 08;36(6):e00170118
pubmed: 32520126
Rev Prat. 2019 Jun;69(6):679-682
pubmed: 31626434
BMC Public Health. 2017 Jul 17;18(1):23
pubmed: 28716015
Malar J. 2016 Jun 09;15:315
pubmed: 27277831
AIDS Care. 2019 Apr;31(4):498-504
pubmed: 30286608
Sociol Health Illn. 1982 Jul;4(2):167-82
pubmed: 10260456